Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is licensed for subcutaneous injection into three sites: the abdomen, the front of the thigh, or the upper arm. All three deliver the medicine into the layer of fatty tissue just beneath the skin, and the NHS tirzepatide medicines page confirms that rotating between these sites with each weekly dose is part of the standard guidance. Choosing the right spot (and using it correctly) affects both comfort and consistent absorption, so it is worth understanding the practicalities before your first injection.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro SmPC, published on the Electronic Medicines Compendium (eMC), identifies three acceptable subcutaneous injection sites: the abdomen (excluding a two-inch radius around the navel), the front or outer thigh, and the upper outer arm. These were selected because each carries enough subcutaneous fat tissue in most adults to allow reliable absorption of the medicine.
Pharmacokinetic data from the SURMOUNT clinical programme (involving thousands of adults across multiple trials) showed no clinically meaningful difference in tirzepatide blood levels between these three sites. In other words, from an absorption standpoint, the guidance is site-neutral. The practical differences come down to ease of access and individual comfort. If you want a detailed walkthrough of each option, our page on where to inject tirzepatide covers the abdomen, thigh, and upper arm in full. The thigh works well when self-injecting in a seated position. The upper arm is fine if someone else administers the dose, but can be awkward to pinch adequately when injecting yourself.
A question our prescribers hear most weeks is whether injecting into the stomach causes more nausea than the thigh or arm. There is no good clinical evidence that it does. Nausea with tirzepatide is centrally mediated (it relates to how the medicine acts on appetite-regulating pathways in the brain and gut) not to where the pen enters the skin.
Injecting repeatedly into the same small patch of skin causes the fatty tissue to become thickened and fibrous over time, a condition called lipohypertrophy. Medicine injected into a lipohypertrophic area absorbs unpredictably (sometimes faster, sometimes slower) which can undermine the steady weekly profile that tirzepatide's dosing schedule is designed to produce.
Rotation does not mean jumping between all three body regions every week. A simple, consistent pattern within one region (moving a centimetre or two from the previous spot) is effective. Some people mark a rough mental grid across the abdomen and work around it; others alternate thighs. The important principle is that no single spot gets used two weeks in a row.
If you notice a lump, firmness or discoloration at a previous injection site, avoid that area until it has fully resolved. Injecting into skin that is red, bruised, tender or broken is not recommended for any site. For a fuller look at the specific mechanics of injecting into the stomach region, our page on where in the stomach to inject Mounjaro goes into more detail on the abdomen specifically.
Storage also plays a role in a comfortable injection. A pen taken straight from the fridge will feel noticeably colder at the injection site; letting it reach room temperature for a few minutes first often improves comfort. The rules on how long Mounjaro can stay out of the fridge are strict, so read our guide on Mounjaro refrigeration before adjusting your routine.
Site is only part of the picture. Technique has a significant influence on how the injection feels and whether the full dose is delivered. The KwikPen is designed to be held at 90 degrees to the skin, pressed firmly against the injection site until the safety lock releases, and held in place until the injection is complete, the pen audibly clicks when the dose has been delivered. Choosing the right moment for your dose is just as important as technique, and our guide on when to inject Mounjaro explains how to build a consistent weekly schedule that works for you.
Pinching the skin gently before pressing the pen helps ensure the needle reaches subcutaneous tissue rather than muscle, particularly for people with less body fat at the chosen site. Once the dose is done, releasing the pinch before withdrawing the pen is the conventional advice to minimise bruising.
Cleaning the site with an alcohol swab beforehand is standard practice; individually wrapped swabs make this straightforward. Used pens are sharps and must be disposed of in an approved sharps container, not a household bin. For step-by-step injection guidance beyond site selection, the Mounjaro injection overview covers the full process, and the patient information leaflet inside the pack remains the definitive clinical reference for technique.
If you are considering starting Mounjaro or are mid-treatment and have questions about how it fits your situation, our clinical team at nume reviews every consultation personally. For context on what private treatment costs and what that price includes, the Mounjaro price comparison page lays it out clearly. When you are ready to take the next step, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.